BIOMAT Database Logo BIOMAT Database Logo

Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs. 1994

J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
King's College School of Medicine and Dentistry, Denmark Hill, London, UK.

OBJECTIVE To identify the source of intestinal blood loss in rheumatoid arthritis patients being treated with nonsteroidal antiinflammatory drugs (NSAIDs) and assess the response to sulfasalazine and other disease-modifying antirheumatic drugs (DMARDs). METHODS Intestinal inflammation, blood loss, and gastroduodenal damage, and the response to treatment with DMARDs, were assessed in 46 patients taking NSAIDs. RESULTS Intestinal inflammation and blood loss correlated significantly with one another (r = 0.43, P < 0.003), but not with the macroscopic or microscopic appearance of the gastroduodenal mucosa. Sulfasalazine reduced both intestinal inflammation and blood loss, whereas the other DMARDs did not. CONCLUSIONS The small intestine is the main site of mild chronic blood loss in patients receiving NSAIDs, and this blood loss can be reduced with sulfasalazine treatment.

UI MeSH Term Description Entries
D007205 Indium Radioisotopes Unstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes. Radioisotopes, Indium
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004751 Enteritis Inflammation of any segment of the SMALL INTESTINE. Enteritides
D005260 Female Females
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents

Related Publications

J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.
September 1987, Gastroenterology,
J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
June 1990, Current opinion in rheumatology,
J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
June 1991, Current opinion in rheumatology,
J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
June 1989, Current opinion in rheumatology,
J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
On the non-specific antiinflammatory effects of other-than-antirheumatic drugs. Psychotropic drugs, inflammation and antiinflammatory drugs.
January 1985, International journal of tissue reactions,
J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures.
April 1988, Gastroenterology,
J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
Effect of disease modifying antirheumatic drugs and nonsteroidal antiinflammatory drugs upon cellular and fibronectin responses in a pleurisy model.
December 1985, The Journal of rheumatology,
J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine.
May 1994, Current opinion in rheumatology,
J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamine.
May 1993, Current opinion in rheumatology,
J Hayllar, and T Smith, and A Macpherson, and A B Price, and M Gumpel, and I Bjarnason
Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
May 1996, Current opinion in rheumatology,
Copied contents to your clipboard!